Investments
Investor-Ready: Growth and Governance Series – Part 2: The Investor View
This Investor-Ready Series has been designed for founders, senior leaders, and operational teams in early-stage companies. Join legal, regulatory, forensic, behavioural, and cultural experts from Ropes & Gray and FRA who draw on their deep experience with regulatory and financial cr...
Investor-Ready: Growth and Governance Series – Part 2: The Investor View
This Investor-Ready Series has been designed for founders, senior leaders, and operational teams in early-stage companies. Join legal, regulatory, forensic, behavioural, and cultural experts from Ropes & Gray and FRA who draw on their deep experience with regulatory and financial cr...
From Innovation to Impact - POSTPONED
Due to unforeseen circumstances this event has been postponed. Registered attendees will be notified directly. Thank you for your patience and understanding. Enabling the next generation of science-driven companiesFor researchers, spin-outs and start-ups ...
PEM advises Prestige Purchasing Holdings Ltd on its acquisition by Entegra Europe UK Ltd.
PEM has advised Prestige Purchasing Holdings Limited on its acquisition by Entegra Europe UK Limited, a subsidiary of Sodexo S.A., in a transaction that strengthens Entegra’s position in the UK hospitality and procurement sector.The transaction sees Entegra Europe UK acquire 100% of Pre...
STORM Therapeutics secures $56 million series C financing and doses first patient in phase 2 Sarcoma Trial of STC‑15
The proceeds will support the advancement of STC-15 in a Phase 2 study in select sarcoma indicationsFirst‑in‑class METTL3 inhibitor reprograms malignant progenitor cells by modulating mRNA methylation16 April 2026, Cambridge, UK: STORM Therapeutics Ltd., the clinical stage company targe...
Cambridge Index advances 6.7%
The Cambridge Index climbed 1,737.5 points or 6.7% to close at 27,554.0, as ten out of the top ten index heavyweights posted weekly gains in their share price. ...
Bridging Cambridge’s MedTech scale-up gap: the missing link between prototype and production
Cambridge leads in early-stage MedTech innovation, but many promising ideas stall when moving from lab prototypes to clinical-ready devices. The core challenge lies in fragmented, early-stage manufacturing and regulatory pathways, often pushing companies to look overseas. This reflects ...
The Common Thread — Monthly Networking Morning
Kickstart your day by connecting with brilliant people and opening doors to new opportunities.Join us at University Arms, in collaboration with the wonderful Neil Bharadwa at The Cambridge Fruit Company, for The Common Thread. A relaxed monthly networking morning bringing together Cambr...
Your Journey to Business Exit: Preparing for Sale.
Join PEM’s Corporate Finance team and Barclays for a joint webinar as part of our Journey to Business Exit series, where we will explore the key steps involved in preparing your business for sale. ...
Cambridge to establish Rokos School of Government
Record-breaking donation will enable new School to prepare tomorrow’s leaders to tackle the world’s biggest problems. ...